AirSeal®: Fact or Fiction

In our previous blog, we uncovered fact and fiction about CONMED’s AirSeal®, the new standard of care for insufflators. Today, we’re debunking even more myths about AirSeal® to see if it’s truly fact or fiction.

  • Published: 1/22/2025
  • 2 min
FACT
-
OR
-
FICTION
AirSeal® is only for robotic-assisted laparoscopic surgery.
FICTION
AirSeal® is for every minimally invasive surgery in the abdominal and thoracic cavities for both adult and pediatric patients.
FACT
-
OR
-
FICTION
AirSeal® has been used to treat over 7.5 million patients.
FACT
AirSeal® is used in over 4,000 facilities in 80 countries to treat over 7.5 million patients.
FACT
-
OR
-
FICTION
High-flow conventional insufflation provides stability and improves patient outcomes.
FICTION
There is no evidence that suggests high-flow conventional insufflation improves stability or patient outcomes. AirSeal® is the only insufflation system backed by clinical data showing improved patient outcomes at low pressure.
There’s still more to AirSeal® than meets the eye. From its proprietary cannula design to its data-backed improvement of patient outcomes, AirSeal® is changing the insufflation game.

Try AirSeal® in your hospital.

Schedule A Demo